Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Antiparkinson Agents/*administration & dosage"'
Autor:
Chanawat Anan, Roongroj Bhidayasiri, Teus van Laar, K. Ray Chaudhuri, Aukkritthiwat Phimpha, Onanong Phokaewvarangkul
Publikováno v:
Parkinsonism & Related Disorders, 91, 146-151. Elsevier
INTRODUCTION: Although continuous subcutaneous apomorphine infusion (CSAI) is an effective therapy for Parkinson's disease (PD) with motor fluctuations, data from Asian cohorts is limited. The therapy is often discontinued due to the complexity of it
Autor:
Lacramioara Perju-Dumbrava, Lars Bergmann, Anjum Misbahuddin, Francesc Valldeoriola, Stephen Wørlich Pedersen, Chris van der Linden, Stephan Bohlhalter, Erik H. Danielsen, David, Maurizio Zibetti, Björn Hauptmann, Oriol De Fabregues, Ashley Yegin, Martin Nevrly, K. Ray Chaudhuri, Jeff Blackie, M.M. Ponsen, Christoph Redecker, Anne Jeanjean, Kenn Freddy Pedersen, Jan Kassubek, Mihaela Simu, Philippe Busson, Barbara A. Pickut, Pierre R. Burkhard, József Attila Szász, Per Odin, Bogdan Ovidiu Popescu, Ene Amalia, Angelo Antonini, Robert Jech, Thomas E. Kimber, Matthias Bode, Kari Anne Bjørnarå, Ivan Milanov, Bruno Bergmans, Espen Dietrichs, Luc Defebvre, Christofer Lundqvist, Jesper Clausen, Michaela Kaiserová, Valérie Delvaux, Werner Poewe, Martin Wolz, Sophie Dethy, Jaime Kulisevsky, Cleanthe Spanaki, Anette Storstein, Michel Rijntjes, F. Ory Magne, Pietro Marano, T. van Laar, Tove Henriksen, Christian Winkler, Ovidiu Bajenaru, Spyridon Konitsiotis, Michel Van Zandijcke, Ransmayr Gerhard, F. Viallet, Koray Onuk, Guy Arnold, Kirsten Hahn, Jo Leenders, Mariachiara Sensi, Jorge Hernández-Vara, Zikos Panayiotis, Nicola Modugno, Volker Tomantschger, Matilde Calopa, Zvezdan Pirtošek, Paul Bourgeois, Graziano Gusmaroli, Christoph Schrader, Ioan Buraga, Víctor Puente, Rejko Krüger, Alexander Storch, Tatiana Witjas
Publikováno v:
Parkinsonism & related disorders, Vol. 45, p. 13-20 (2017)
Parkinsonism & related disorders, 45
Antonini, A, Poewe, W, Chaudhuri, K R, Jech, R, Pickut, B, Pirtošek, Z, Szasz, J, Valldeoriola, F, Winkler, C, Bergmann, L, Yegin, A, Onuk, K, Barch, D, Odin, P, Amalia, E, Arnold, G, Bajenaru, O, Bergmans, B, Bjornara, K A, Blackie, J, Bode, M, Bourgeois, P, Bohlhalter, S, Buraga, I, Burkhard, P R, Busson, P, Calopa, M, Clausen, J, Danielsen, E H, Defebvre, L, Delvaux, V, Dethy, S, Dietrichs, E, De Fabregues, O, Gerhard, R, Gusmaroli, G, Hahn, K, Hauptmann, B, Henriksen, T, Hernandez-Vara, J, Jeanjean, A, Kaiserova, M, Kassubek, J, Kimber, T, Konitsiotis, S, Krüger, R, Kulisevsky, J, Leenders, J, Lundqvist, C, Ory Magne, F & GLORIA study co-investigators 2017, ' Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry ', Parkinsonism and Related Disorders, vol. 45, pp. 13-20 . https://doi.org/10.1016/j.parkreldis.2017.09.018
PARKINSONISM & RELATED DISORDERS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Parkinsonism and related disorders
Parkinsonism & Related Disorders, Vol. 45 (2017) pp. 13-20
Parkinsonism & Related Disorders, 45, 13-20. Elsevier
Antonini, A, Poewe, W, Chaudhuri, K R, Jech, R, Pickut, B, Pirtošek, Z, Szasz, J, Valldeoriola, F, Winkler, C, Bergmann, L, Yegin, A, Onuk, K, Barch, D, Odin, P, Amalia, E, Arnold, G, Bajenaru, O, Bergmans, B, Bjornara, K A, Blackie, J, Bode, M, Bourgeois, P, Bohlhalter, S, Buraga, I, Burkhard, P R, Busson, P, Calopa, M, Clausen, J, Danielsen, E H, Defebvre, L, Delvaux, V, Dethy, S, Dietrichs, E, De Fabregues, O, Gerhard, R, Gusmaroli, G, Hahn, K, Hauptmann, B, Henriksen, T, Hernandez-Vara, J, Jeanjean, A, Kaiserova, M, Kassubek, J, Kimber, T, Konitsiotis, S, Krüger, R, Kulisevsky, J, Leenders, J, Lundqvist, C, Ory Magne, F, Marano, P, Milanov, I, Modugno, N, Misbahuddin, A, Nevrly, M, Panayiotis, Z, Pedersen, K F, Pedersen, S W, Perju-Dumbrava, L, Ponsen, M M, Popescu, B O, Rijntjes, M, Puente, V, Redecker, C, Schrader, C, Sensi, M, Simu, M, Spanaki, C, Storch, A, Storstein, A, Tomantschger, V, van der Linden, C, van Laar, T, Viallet, F, Witjas, T, Wolz, M, Zibetti, M & Van Zandijcke, M 2017, ' Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry ', Parkinsonism & Related Disorders . https://doi.org/10.1016/j.parkreldis.2017.09.018
Parkinsonism & related disorders, 45
Antonini, A, Poewe, W, Chaudhuri, K R, Jech, R, Pickut, B, Pirtošek, Z, Szasz, J, Valldeoriola, F, Winkler, C, Bergmann, L, Yegin, A, Onuk, K, Barch, D, Odin, P, Amalia, E, Arnold, G, Bajenaru, O, Bergmans, B, Bjornara, K A, Blackie, J, Bode, M, Bourgeois, P, Bohlhalter, S, Buraga, I, Burkhard, P R, Busson, P, Calopa, M, Clausen, J, Danielsen, E H, Defebvre, L, Delvaux, V, Dethy, S, Dietrichs, E, De Fabregues, O, Gerhard, R, Gusmaroli, G, Hahn, K, Hauptmann, B, Henriksen, T, Hernandez-Vara, J, Jeanjean, A, Kaiserova, M, Kassubek, J, Kimber, T, Konitsiotis, S, Krüger, R, Kulisevsky, J, Leenders, J, Lundqvist, C, Ory Magne, F & GLORIA study co-investigators 2017, ' Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry ', Parkinsonism and Related Disorders, vol. 45, pp. 13-20 . https://doi.org/10.1016/j.parkreldis.2017.09.018
PARKINSONISM & RELATED DISORDERS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Parkinsonism and related disorders
Parkinsonism & Related Disorders, Vol. 45 (2017) pp. 13-20
Parkinsonism & Related Disorders, 45, 13-20. Elsevier
Antonini, A, Poewe, W, Chaudhuri, K R, Jech, R, Pickut, B, Pirtošek, Z, Szasz, J, Valldeoriola, F, Winkler, C, Bergmann, L, Yegin, A, Onuk, K, Barch, D, Odin, P, Amalia, E, Arnold, G, Bajenaru, O, Bergmans, B, Bjornara, K A, Blackie, J, Bode, M, Bourgeois, P, Bohlhalter, S, Buraga, I, Burkhard, P R, Busson, P, Calopa, M, Clausen, J, Danielsen, E H, Defebvre, L, Delvaux, V, Dethy, S, Dietrichs, E, De Fabregues, O, Gerhard, R, Gusmaroli, G, Hahn, K, Hauptmann, B, Henriksen, T, Hernandez-Vara, J, Jeanjean, A, Kaiserova, M, Kassubek, J, Kimber, T, Konitsiotis, S, Krüger, R, Kulisevsky, J, Leenders, J, Lundqvist, C, Ory Magne, F, Marano, P, Milanov, I, Modugno, N, Misbahuddin, A, Nevrly, M, Panayiotis, Z, Pedersen, K F, Pedersen, S W, Perju-Dumbrava, L, Ponsen, M M, Popescu, B O, Rijntjes, M, Puente, V, Redecker, C, Schrader, C, Sensi, M, Simu, M, Spanaki, C, Storch, A, Storstein, A, Tomantschger, V, van der Linden, C, van Laar, T, Viallet, F, Witjas, T, Wolz, M, Zibetti, M & Van Zandijcke, M 2017, ' Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry ', Parkinsonism & Related Disorders . https://doi.org/10.1016/j.parkreldis.2017.09.018
Introduction This registry evaluated the 24-month safety and efficacy of levodopa-carbidopa intestinal gel (LCIG) treatment in advanced Parkinson's disease (PD) patients under routine clinical care. Methods Motor fluctuations, dyskinesia, non-motor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933eaa5784d83f91f9168f2f9647c7fe
https://hdl.handle.net/2078.1/217860
https://hdl.handle.net/2078.1/217860
Autor:
Stig Rehncrona, Olof Sydow, A. L. Benabid, Bo Johnels, Pierre Pollak, F Johansson, Marwan Hariz, Paul Krack, R. Ekberg, François Alesch, A. Bosch, Björn A. Meyerson, M M Pinter, L-E Augustinsson, F. von Raison, J-P N'Guyen, Johannes D. Speelman
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 79, No 6 (2008) pp. 694-699
Journal of neurology, neurosurgery, and psychiatry, 79(6), 694-699. BMJ Publishing Group
Journal of neurology, neurosurgery, and psychiatry, 79(6), 694-699. BMJ Publishing Group
AIM: To evaluate the results of ventral intermediate (Vim) thalamic deep brain stimulation (DBS) in patients with tremor predominant Parkinson's disease (PD) at 6 years post surgery. METHODS: This was a prolonged follow-up study of 38 patients from e
Autor:
Pierre Pollak, Valérie Fraix, Paul Krack, Claire Ardouin, Aurélie Funkiewiez, Nadège Van Blercom, Alim-Louis Benabid, Jing Xie, Elena Moro
Publikováno v:
Movement Disorders, Vol. 18, No 5 (2003) pp. 524-30
High-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves the motor symptoms of Parkinson's disease (PD). Opposite changes in mood, such as mania or depression, have been reported after surgery, but it is not known whether
Autor:
Claire Ardouin, Jean-Luc Houeto, A. L. Benabid, A. M. Bonnet, Bernard Pillon, Yves Agid, P. Damier, Pierre Pollak, Paul Krack, Hélène Klinger
Publikováno v:
Neurology, Vol. 55, No 3 (2000) pp. 411-418
Background: In a previous study on a consecutive series of 62 patients with PD, the authors showed that bilateral subthalamic or pallidal continuous high-frequency deep brain stimulation (DBS) affects neither memory nor executive functions 3 to 6 mon
Publikováno v:
Revue médicale suisse, Vol. 8, No 339 (2012) pp. 926-9
Therapeutic strategies for essential tremor (ET) and Parkinson's disease (PD) can be divided into two successive steps, one based on oral medications and the other, more invasive, using pumps or functional neurosurgery. When ET becomes refractory to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::92e24b10e23ea355188ff0980a970153
https://archive-ouverte.unige.ch/unige:32853
https://archive-ouverte.unige.ch/unige:32853
Publikováno v:
Clinical Interventions in Aging
Clinical Interventions in Aging, Vol. 5 (2010) pp. 229-38
Clinical Interventions in Aging, Vol. 5 (2010) pp. 229-38
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD). Compared with other available dopaminergic therapies, dopamine replacement with LD is associa
Publikováno v:
Clinical Interventions In Aging, vol. 5, pp. 229-238
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD). Compared with other available dopaminergic therapies, dopamine replacement with LD is associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::62b45aa93c978945c7c32c37a0232e8f
https://serval.unil.ch/resource/serval:BIB_312BEA16C2AD.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_312BEA16C2AD.P001/REF.pdf
Autor:
E, Lohmann, S, Thobois, S, Lesage, E, Broussolle, S Tezenas, du Montcel, M-J, Ribeiro, P, Remy, A, Pelissolo, B, Dubois, L, Mallet, P, Pollak, Y, Agid, A, Brice, J-M, Warter
Publikováno v:
Neurology, Vol. 72, No 2 (2009) pp. 110-116
Objective: To establish phenotype–genotype correlations in early-onset Parkinson disease (EOPD), we performed neurologic, neuropsychological, and psychiatric evaluations in a series of patients with and without parkin mutations.Background: Parkin (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e97720e15dc65f5d5b0c523b4d1e07
https://europepmc.org/articles/PMC2677494/
https://europepmc.org/articles/PMC2677494/
Autor:
H. Russmann, Pierre Burkhard, Christian Wider, Bernadette Robert, Jean-Guy Villemure, Julien Bogousslavsky, François Vingerhoets
Publikováno v:
Archives of Neurology, Vol. 63, No 7 (2006) pp. 951-5
Background Long-duration response (LDR) to levodopa is supposed to decrease with Parkinson disease (PD) progression, but direct observation of this response in advanced PD has never been performed. Objective To study the LDR to levodopa in patients w